The rise of cannabis in the wellness space, the legal market expansion, and consumer sentiment shifting towards medical cannabis as a viable alternative to prescription medications are contributing to potential disruption of the pharmaceutical market.
“The pharmaceutical sectors across Europe, Asia and North America are making strides into the recognition and application of cannabis relative to more traditional medicine, making this a critical time to best understand what the patient needs and wants, not to mention why,” noted New Frontier Data Founder and Executive Chair, Giadha A.
We maintain a neutral position on the merits of cannabis legalization through comprehensive and transparent data analysis and projections that shape industry trends, dynamics, demand and opportunity drivers.